View Author
scopus: 34573861200

Valsecchi, M.G.

( M.G. Valsecchi)


patient infant leukemia group study lymphoblastic leukemia lymphoblastic rearrangement treatment expression children blood sample analysis fication figure childhood level month relapse outcome signi target result protocol mll-rearranged response disease diagnosis mll-rearranged infant erasmus mc number cancer interfant strati gene expression prednisone signi ficantly table translocation lymphoblastic leukaemia prognostic therapy flt 3 trial methylation induction survival mll-af fusion erasmu t-all concentration probe phase identi university pharmacokinetic ficantly flt 3 expression volume death 1 year mll rearrangements hospital article detection sensitivity receptor library germany remission chemotherapy prednisolone pattern vaccination breakpoint pkc 412 clearance daunorubicin




10 Most Recent Publications

The controversy of varicella vaccination in children with acute lymphoblastic leukemia (Article)
Caniza, M.A. Hunger, S.P. Liang, D. Ohara, A. Okamura, J. Pieters, R. Schmiegelow, K. Schrappe, M. Stark, B. Stary, J. Schrauder, A. Valsecchi, M.G. Pui, C.H. Masera, G. Baruchel, A. Biondi, A. Devidas, M. Horibe, K.
2012-01-01
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 2000 study (Article)
Schrappe, M. Valsecchi, M.G. Reiter, A. Basso, G. Klingebiel, T. Messina, C. Ratei, R. Cazzaniga, G. Koehler, R. Locatelli, F. Schäfer, B.W. Aricò, M. Bartram, C.R. Welte, K. Dongen, J.J.M. van Gadner, H. Biondi, A. Conter, V. Schrauder, A. Panzer-Grümayer, R. Möricke, A. Parasole, R. Zimmermann, M. Dworzak, M.N. Buldini, B.
2011-08-25
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: Results from the Interfant-99 Study (Article)
Mann, G. Attarbaschi, A. Szczepański, T. Ferster, A. Janka-Schaub, G.E. Rubnitz, J.E. Silverman, L.B. Stary, J. Campbell, M. Li, C.K. Suppiah, R. Biondi, A. Schrappe, M. Vora, A. Valsecchi, M.G. Pieters, R. Lorenzo, P. de Peters, A.C.B. Hann, I. Rossi, G. de Felice, M. Lausen, B. Leblanc, T.M.
2010-10-14
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFMALL 2000 study (Article)
Conter, V. Bartram, C.R. Stanulla, M. Locatelli, F. Basso, G. Niggli, F. Barisone, E. Henze, G. Ludwig, W.D. Haas, O.A. Cazzaniga, G. Koehler, R. Valsecchi, M.G. Silvestri, D. Bradtke, J. Parasole, R. Beier, R. Dongen, J.J.M. van Biondi, A. Schrappe, M. Schrauder, A. Panzer-Grümayer, R. Möricke, A. Aricò, M. Zimmermann, M. Mann, G. Rossi, G. de
2010-04-22
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants (Article)
Stam, R.W. Schneider, P. Hagelstein, J. Linden, M.H. van der Stumpel, D.J.P.M. Menezes, R.X. de Lorenzo, P. de Valsecchi, M.G. Pieters, R.
2010-04-08
Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment (Article)
Jung, R. Jacobs, U. Teigler-Schlegel, A. Panzer-Gruemayer, E.R. Dongen, J.J.M. van Schrappe, M. Boer, M.L. den Pieters, R. Rascher, W. Metzler, M. Krumbholz, M. Langer, T. Keller, T. Lorenzo, P. de Valsecchi, M.G. Velden, V.H.J. van der Moericke, A. Stanulla, M.
2010-04-01
Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol (Article)
Hempel, G. Relling, M.V. Rossi, G. de Stary, J. Lorenzo, P. de Valsecchi, M.G. Barisone, E. Boos, J. Pieters, R.
2010-03-01
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia (Article)
Stam, R.W. Boer, M.L. den Pieters, R. Schneider, P. Boer, J.B. de Hagelstein, J. Valsecchi, M.G. Lorenzo, P. de Sallan, S.E. Brady, H.J.M. Armstrong, S.A.
2010-02-04
Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options (Article)
Stumpel, D.J.P.M. Schneider, P. Roon, E.H.J. van Boer, J.M. Lorenzo, P. de Valsecchi, M.G. Menezes, R.X. de Pieters, R. Stam, R.W.
2009-12-24
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol (Article)
Linden, M.H. van der Valsecchi, M.G. Rubnitz, J.E. Stary, J. Szczepański, T. Vora, A. Ferster, A. Hovi, L. Silverman, L.B. Pieters, R. Lorenzo, P. de Möricke, A. Janka, G. Leblanc, T.M. Felice, M. Biondi, A. Campbell, M. Hann, I.
2009-10-29
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile